Theravance Biopharma, Inc.
TBPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001583107
In the last 90 days, Theravance Biopharma, Inc. insiders filed 0 open-market purchases and 3 sales; 179 institutions reported holding it in 13F filings for Q2 2026, worth $817.5M in total; no superinvestor holds it.
Holders of 5% or more of TBPH
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Theravance Biopharma, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Madison Avenue Partners, LP | 13G/A | 17.70%9.21M shares | – | Sep 27, 20214 filings | Aug 14, 2026 | SEC |
| Newtyn Management, LLC | 13G/A | 6.70%3.43M shares | −1.80 ppfrom 8.50% | Feb 14, 20253 filings | Aug 14, 2026 | SEC |
| BlackRock, Inc. | 13G/A | 6.50%3.24M shares | – | Apr 30, 20251 filing | Apr 30, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
43 Schedule 13D and 13G filings on Theravance Biopharma, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Sep 25, 20264:01 PM ET | Weiss Asset Management LPand 3 others | 13D/A | 0.00%0 shares | −14.50 ppfrom 14.50%Below 5% | Sep 23, 2026 | SEC |
| Aug 14, 20264:15 PM ET | Newtyn Management, LLCand 1 other | 13G/A | 6.70%3.43M shares | −1.80 ppfrom 8.50% | Jun 30, 2026 | SEC |
| Aug 14, 202610:09 AM ET | Madison Avenue Partners, LPand 5 others | 13G/A | 17.70%9.21M shares | – | Jun 30, 2026 | SEC |
| Mar 25, 20264:05 PM ET | Weiss Asset Management LPand 3 others | 13D/A | 14.50%7.46M shares | – | Mar 23, 2026 | SEC |
| Feb 17, 20264:15 PM ET | Newtyn Management, LLCand 1 other | 13G/A | 8.50%4.30M shares | −1.20 ppfrom 9.70% | Dec 31, 2025 | SEC |
| Apr 30, 20251:14 PM ET | BlackRock, Inc. | 13G/A | 6.50%3.24M shares | – | Mar 31, 2025 | SEC |
| Feb 14, 20254:05 PM ET | Newtyn Management, LLCand 1 other | 13G/A | 9.70%4.76M shares | – | Dec 31, 2024 | SEC |
| Mar 5, 2024 | Weiss Asset Management LP | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Irenic Capital Management LP | 13GOld format | – | New | – | SEC |
| Feb 13, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 8, 20244:54 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Aug 14, 2023 | Weiss Asset Management LP | 13D/AOld format | – | – | – | SEC |
| Jul 10, 2023 | Baupost Group LLCSuperinvestorBaupost Group | 13G/AOld format | – | – | – | SEC |
| Apr 12, 2023 | Weiss Asset Management LP | 13DOld format | – | – | – | SEC |
| Feb 14, 2023 | Madison Avenue Partners, LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | OrbiMed Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2023 | Baupost Group LLCSuperinvestorBaupost Group | 13G/AOld format | – | – | – | SEC |
| Feb 10, 20234:40 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2023 | Weiss Asset Management LP | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Jan 30, 2023 | Barclays PLC | 13GOld format | – | New | – | SEC |
| Sep 20, 2022 | GSK plc | 13D/AOld format | – | – | – | SEC |
| Aug 3, 2022 | GSK plc | 13D/AOld format | – | – | – | SEC |
| Jun 16, 2022 | Weiss Asset Management LP | 13GOld format | – | New | – | SEC |
| Apr 21, 2022 | Odre 2005 Slu | 13GOld format | – | New | – | SEC |
| Feb 14, 2022 | Madison Avenue Partners, LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Point72 Asset Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Baupost Group LLCSuperinvestorBaupost Group | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | OrbiMed Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | GSK plc | 13D/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 3, 20224:29 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Oct 12, 2021 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Oct 8, 2021 | Wellington Management Group LLP | 13G/AOld format | – | – | – | SEC |
| Sep 27, 2021 | Madison Avenue Partners, LP | 13GOld format | – | New | – | SEC |
| Sep 7, 2021 | Point72 Asset Management, L.P. | 13GOld format | – | New | – | SEC |
| Apr 12, 2021 | Wellington Management Group LLP | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Baupost Group LLCSuperinvestorBaupost Group | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | OrbiMed Advisors LLC | 13GOld format | – | New | – | SEC |
| Feb 10, 2021 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2021 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 5, 20218:03 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 3, 2021 | Wellington Management Group LLP | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Theravance Biopharma, Inc. shares.
No Form 144 notices for Theravance Biopharma, Inc. are on file.